Background: Osteoarthritis (OA) is a degenerative joint disease that causes a variety of adverse health effects. Considering the need to identify additional effective therapeutic options for OA therapy, we investigated the effect of co-injection of apigenin and synovial membrane-derived mesenchymal stem cells (SMMSCs) on OA in male rats’ knee joints. Methods: The study was performed in 2019 at the Department of Pharmacology, Shiraz University of Medical Sciences, Shiraz, Iran. Anterior cruciate ligament transection (ACLT) was used to induce OA. For three weeks, male Sprague-Dawley rats (eight groups, n=6 each) were treated once-weekly with intra-articular injections of apigenin alone or in combination with SMMSC (three million cells), phosphate-buffered saline, or hyaluronic acid. After three months, the interleukin 1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α), superoxide dismutase (SOD), and malondialdehyde (MDA) levels were measured in the cartilage homogenate. The expression of extracellular matrix (ECM) components including collagen 2a1, aggrecan, IL-1β, TNF-α, inducible nitric oxide synthase (iNOS), transcription factor SOX-9, and matrix metalloproteinases 3 and 13 were assessed using real-time polymerase chain reaction (RT-PCR) analysis. Radiological evaluation and histopathological assessment were used to evaluate the knees. Results: Levels of TNF-α (P=0.009), MDA (P>0.001), and IL-1β (p <0.001) decreased and the level of SOD increased (P=0.004) in the apigenin 0.3 µM with SMMSCs group. RT-PCR analysis indicated that IL-1β in the apigenin 0.3 µM with SMMSCs group reduced significantly (p <0.001). This group also exhibited increased expression levels of SOX-9, collagen 2a1, and aggrecan (p <0.001). Conclusion: Apigenin may have supplementary beneficial effects on cell therapy in a rat model of OA due to its possible effect on the reduction of oxidative stress, suppression of inflammation, and promotion of production of ECM components. |
- Silverwood V, Blagojevic-Bucknall M, Jinks C, Jordan JL, Protheroe J, Jordan KP. Current evidence on risk factors for knee osteoarthritis in older adults: a systematic review and meta-analysis. Osteoarthritis Cartilage. 2015;23:507-15. doi: 10.1016/j.joca.2014.11.019. PubMed PMID: 25447976.
- Marchev AS, Dimitrova PA, Burns AJ, Kostov RV, Dinkova-Kostova AT, Georgiev MI. Oxidative stress and chronic inflammation in osteoarthritis: can NRF2 counteract these partners in crime? Ann N Y Acad Sci. 2017;1401:114-35. doi: 10.1111/nyas.13407. PubMed PMID: 28662306.
- Kalaitzoglou E, Griffin TM, Humphrey MB. Innate Immune Responses and Osteoarthritis. Curr Rheumatol Rep. 2017;19:45. doi: 10.1007/s11926-017-0672-6. PubMed PMID: 28718060.
- Wojdasiewicz P, Poniatowski LA, Szukiewicz D. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediators Inflamm. 2014;2014:561459. doi: 10.1155/2014/561459. PubMed PMID: 24876674; PubMed Central PMCID: PMCPMC4021678.
- Sokolove J, Lepus CM. Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations. Ther Adv Musculoskelet Dis. 2013;5:77-94. doi: 10.1177/1759720X12467868. PubMed PMID: 23641259; PubMed Central PMCID: PMCPMC3638313.
- Satue M, Schuler C, Ginner N, Erben RG. Intra-articularly injected mesenchymal stem cells promote cartilage regeneration, but do not permanently engraft in distant organs. Sci Rep. 2019;9:10153. doi: 10.1038/s41598-019-46554-5. PubMed PMID: 31300685; PubMed Central PMCID: PMCPMC6626061.
- Davatchi F, Sadeghi Abdollahi B, Mohyeddin M, Nikbin B. Mesenchymal stem cell therapy for knee osteoarthritis: 5 years follow-up of three patients. Int J Rheum Dis. 2016;19:219-25. doi: 10.1111/1756-185X.12670. PubMed PMID: 25990685.
- Fox BA, Stephens MM. Glucosamine/chondroitin/primorine combination therapy for osteoarthritis. Drugs Today (Barc). 2009;45:21-31. doi: 10.1358/dot.2009.45.1.1314053. PubMed PMID: 19271029.
- Poulet B, Beier F. Targeting oxidative stress to reduce osteoarthritis. Arthritis Res Ther. 2016;18:32. doi: 10.1186/s13075-015-0908-7. PubMed PMID: 26818766; PubMed Central PMCID: PMCPMC4730642.
- Hughes SD, Ketheesan N, Haleagrahara N. The therapeutic potential of plant flavonoids on rheumatoid arthritis. Crit Rev Food Sci Nutr. 2017;57:3601-13. doi: 10.1080/10408398.2016.1246413. PubMed PMID: 27874281.
- Gaballah HH, Gaber RA, Mohamed DA. Apigenin potentiates the antitumor activity of 5-FU on solid Ehrlich carcinoma: Crosstalk between apoptotic and JNK-mediated autophagic cell death platforms. Toxicol Appl Pharmacol. 2017;316:27-35. doi: 10.1016/j.taap.2016.12.012. PubMed PMID: 28025107.
- Ginwala R, Bhavsar R, Chigbu DI, Jain P, Khan ZK. Potential Role of Flavonoids in Treating Chronic Inflammatory Diseases with a Special Focus on the Anti-Inflammatory Activity of Apigenin. Antioxidants (Basel). 2019;8. doi: 10.3390/antiox8020035. PubMed PMID: 30764536; PubMed Central PMCID: PMCPMC6407021.
- Piskin A, Gulbahar MY, Tomak Y, Gulman B, Hokelek M, Kerimoglu S, et al. Osteoarthritis models after anterior cruciate ligament resection and medial meniscectomy in rats. A histological and immunohistochemical study. Saudi Med J. 2007;28:1796-802. PubMed PMID: 18060205.
- Horie M, Sekiya I, Muneta T, Ichinose S, Matsumoto K, Saito H, et al. Intra-articular Injected synovial stem cells differentiate into meniscal cells directly and promote meniscal regeneration without mobilization to distant organs in rat massive meniscal defect. Stem Cells. 2009;27:878-87. doi: 10.1634/stemcells.2008-0616. PubMed PMID: 19350690.
- Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315-7. doi: 10.1080/14653240600855905. PubMed PMID: 16923606.
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402-8. doi: 10.1006/meth.2001.1262. PubMed PMID: 11846609.
- Wright RW, Group M. Osteoarthritis Classification Scales: Interobserver Reliability and Arthroscopic Correlation. J Bone Joint Surg Am. 2014;96:1145-51. doi: 10.2106/JBJS.M.00929. PubMed PMID: 25031368; PubMed Central PMCID: PMCPMC4083772.
- Khoubnasabjafari M, Ansarin K, Jouyban A. Critical review of malondialdehyde analysis in biological samples. Current Pharmaceutical Analysis. 2016;12:4-17. doi: 10.2174/1573412911666150505185343
- Hoemann C, Kandel R, Roberts S, Saris DB, Creemers L, Mainil-Varlet P, et al. International Cartilage Repair Society (ICRS) Recommended Guidelines for Histological Endpoints for Cartilage Repair Studies in Animal Models and Clinical Trials. Cartilage. 2011;2:153-72. doi: 10.1177/1947603510397535. PubMed PMID: 26069577; PubMed Central PMCID: PMCPMC4300784.
- Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage. 2006;14:13-29. doi: 10.1016/j.joca.2005.07.014. PubMed PMID: 16242352.
- Babaskina L, Litvinova T, Babaskin D, Winter E, Krylova O. Improving the Chemical Status of Peloids by Adding the Phytocomplex in the Rehabilitation of Patients with Osteoarthritis: Experimental Study. Journal of Pharmaceutical Sciences and Research. 2018;10:1238-42.
- Li G, Yin J, Gao J, Cheng TS, Pavlos NJ, Zhang C, et al. Subchondral bone in osteoarthritis: insight into risk factors and microstructural changes. Arthritis Res Ther. 2013;15:223. doi: 10.1186/ar4405. PubMed PMID: 24321104; PubMed Central PMCID: PMCPMC4061721.
- Man GS, Mologhianu G. Osteoarthritis pathogenesis - a complex process that involves the entire joint. J Med Life. 2014;7:37-41. PubMed PMID: 24653755; PubMed Central PMCID: PMCPMC3956093.
- Barry F, Murphy M. Mesenchymal stem cells in joint disease and repair. Nat Rev Rheumatol. 2013;9:584-94. doi: 10.1038/nrrheum.2013.109. PubMed PMID: 23881068.
- Murphy JM, Dixon K, Beck S, Fabian D, Feldman A, Barry F. Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum. 2002;46:704-13. doi: 10.1002/art.10118. PubMed PMID: 11920406.
- Fu WL, Zhou CY, Yu JK. A new source of mesenchymal stem cells for articular cartilage repair: MSCs derived from mobilized peripheral blood share similar biological characteristics in vitro and chondrogenesis in vivo as MSCs from bone marrow in a rabbit model. Am J Sports Med. 2014;42:592-601. doi: 10.1177/0363546513512778. PubMed PMID: 24327479.
- Diekman BO, Guilak F. Stem cell-based therapies for osteoarthritis: challenges and opportunities. Curr Opin Rheumatol. 2013;25:119-26. doi: 10.1097/BOR.0b013e32835aa28d. PubMed PMID: 23190869; PubMed Central PMCID: PMCPMC3616879.
- Dubey NK, Mishra VK, Dubey R, Syed-Abdul S, Wang JR, Wang PD, et al. Combating Osteoarthritis through Stem Cell Therapies by Rejuvenating Cartilage: A Review. Stem Cells Int. 2018;2018:5421019. doi: 10.1155/2018/5421019. PubMed PMID: 29765416; PubMed Central PMCID: PMCPMC5885495.
- Wang W, Cao W. Treatment of osteoarthritis with mesenchymal stem cells. Sci China Life Sci. 2014;57:586-95. doi: 10.1007/s11427-014-4673-7. PubMed PMID: 24849513.
- Sakaguchi Y, Sekiya I, Yagishita K, Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum. 2005;52:2521-9. doi: 10.1002/art.21212. PubMed PMID: 16052568.
- Bian L, Hou C, Tous E, Rai R, Mauck RL, Burdick JA. The influence of hyaluronic acid hydrogel crosslinking density and macromolecular diffusivity on human MSC chondrogenesis and hypertrophy. Biomaterials. 2013;34:413-21. doi: 10.1016/j.biomaterials.2012.09.052. PubMed PMID: 23084553; PubMed Central PMCID: PMCPMC3578381.
- Medina JJM, Naso LG, Pérez AL, Rizzi A, Okulik NB, Ferrer EG, et al. Apigenin oxidovanadium (IV) cation interactions. Synthesis, spectral, bovine serum albumin binding, antioxidant and anticancer studies. Journal of Photochemistry and Photobiology A: Chemistry. 2017;344:84-100. doi: 10.1016/j.jphotochem.2017.05.007.
- Park JS, Kim DK, Shin HD, Lee HJ, Jo HS, Jeong JH, et al. Apigenin Regulates Interleukin-1beta-Induced Production of Matrix Metalloproteinase Both in the Knee Joint of Rat and in Primary Cultured Articular Chondrocytes. Biomol Ther (Seoul). 2016;24:163-70. doi: 10.4062/biomolther.2015.217. PubMed PMID: 26902085; PubMed Central PMCID: PMCPMC4774497.
- Tantowi NBCA, Lau S, Hussin P, Mohamed S. Apigenin derivatives-rich clinacanthus nutans extract mitigates articular cartilage deterioration in ovariectomized rats with monosodium iodoacetate induced osteoarthritis. Osteoarthritis and Cartilage. 2018;26:S344. doi: 10.1016/j.joca.2018.02.684.
- Vincent TL. IL-1 in osteoarthritis: time for a critical review of the literature. F1000Res. 2019;8. doi: 10.12688/f1000research.18831.1. PubMed PMID: 31249675; PubMed Central PMCID: PMCPMC6589928.
- Kowalski J, Samojedny A, Paul M, Pietsz G, Wilczok T. Effect of apigenin, kaempferol and resveratrol on the expression of interleukin-1beta and tumor necrosis factor-alpha genes in J774.2 macrophages. Pharmacol Rep. 2005;57:390-4. PubMed PMID: 15985724.
- Zhang Q, Ji Q, Wang X, Kang L, Fu Y, Yin Y, et al. SOX9 is a regulator of ADAMTSs-induced cartilage degeneration at the early stage of human osteoarthritis. Osteoarthritis Cartilage. 2015;23:2259-68. doi: 10.1016/j.joca.2015.06.014. PubMed PMID: 26162802.
- Lepetsos P, Papavassiliou AG. ROS/oxidative stress signaling in osteoarthritis. Biochim Biophys Acta. 2016;1862:576-91. doi: 10.1016/j.bbadis.2016.01.003. PubMed PMID: 26769361.
- Raskovic A, Gigov S, Capo I, Paut Kusturica M, Milijasevic B, Kojic-Damjanov S, et al. Antioxidative and Protective Actions of Apigenin in a Paracetamol-Induced Hepatotoxicity Rat Model. Eur J Drug Metab Pharmacokinet. 2017;42:849-56. doi: 10.1007/s13318-017-0407-0. PubMed PMID: 28255865.
|